May 2021

Coastal District of Tamil Nadu, on the eastern coast, Bay of Bengal, 326 K.M, south of the State Capital, Chennai, 145 K.M from Trichy, A middle Town. The District Capital Nagapattinam lies between Northern Latitude 10.7906 degrees and 79.8428 Degrees Eastern Longitude. A District known for its Rich Religious Heritage and Communal Harmony. Nagapattinam district was carved out by bifurcating the Erstwhile composite Thanjavur district on 18.10.1991. Nagapattinam is a unique District with all its historical and cultural significance.

Apollo pharmacy is a leading retail chain of pharmacy and is a unit of - Apollo Hospitals Enterprise Ltd. - Asias largest healthcare group. Our growing Retail Pharmacy network touches lives across the length and breadth of India and we serve 200000+ customers a day. With over 30 years of retailing experience, customer-focused service and brand value our network spans out to 2000+ retail pharmacies through which we have been serving our customers for their healthcare needs 24x7.

The National Forensic Sciences University with the status of an Institution of National Importance is the world’s first and only University dedicated to Forensic, behavioral, cybersecurity, digital forensics, and allied Sciences. It was established by the Government of India through Act, 2020 (32 of 2020) with the objective of fulfilling the acute shortage against the increasing demand for forensic experts in the country and around the world.

Piramal Healthcare Limited A major force in the pharmaceuticals and healthcare segment, Piramal Healthcare Limited, incorporating Healthcare Solutions & Pharma Solutions, has an unequivocal vision – to become the most admired pharmaceutical company, with leadership in market share and profits.

Post : Executive QA

Shilpa Medicare Limited started its operations as API manufacturer way back in 1987 at Raichur, Karnataka, India. The commercial production in the SML was started in November 1989. Today Shilpa Medicare Limited is a global brand in manufacturing and supplying of affordable API and Formulation globally in different regulated markets.

Takeda Pharmaceutical Company Limited announced that the U.S. Food & Drug Administration (FDA) has accepted a New Drug Application (NDA) for maribavir for the treatment of CMV infection in those that are refractory with or without resistance (R/R), in solid organ transplant (SOT) or hematopoietic cell transplant (HCT) recipients.

Roche announced interim results from the Phase III IMpower010 study, showing for the first time that treatment with Tecentriq (atezolizumab) following surgery and chemotherapy reduced the risk of disease recurrence or death (disease-free survival; DFS) by 34% (hazard ratio [HR]=0.66, 95% CI: 0.50–0.88) in people with Stage II-IIIA non-small cell lung cancer (NSCLC), whose tumours express PD-L1≥1%, compared with best supportive care (BSC). In this population, median DFS was not yet reached for Tecentriq compared with 35.3 months for BSC.

The Janssen Pharmaceutical Companies of Johnson & Johnson announced the U.S. Food and Drug Administration has granted the accelerated approval of RYBREVANTTM (amivantamab-vmjw) for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by an FDA-approved test, whose disease has progressed on or after platinum-based chemotherapy.